• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Lucid Diagnostics Inc. - Common Stock (NQ:LUCD)

    0.6037 +0.0137 (+2.32%)
    Delayed Quote Updated: 11:59 AM EDT, Oct 6, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Lucid Diagnostics Inc. - Common Stock

    < Previous 1 2 Next >
    News headline image
    October's 4 Best Penny Stocks: High-Risk, High-Reward Picks
    Penny stocks are a risky but potentially rewarding opportunity for investors willing to take on their uncertainty; these stocks may stand out from the pack. 
    Via MarketBeat
    Topics Bankruptcy
    News headline image
    PAVmed and Lucid Diagnostics Provide Strategic Business Update
    From PAVmed Inc.
    Via Business Wire
    News headline image
    PAVmed and Lucid Diagnostics to Provide Strategic Business Update
    From PAVmed Inc.
    Via Business Wire
    News headline image
    PAVmed Partners with Novosound on Ultrasound Imaging Technology
    From PAVmed Inc.
    Via Business Wire
    News headline image
    Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic Industry
    From Lucid Diagnostics Inc.
    Via Business Wire
    News headline image
    PAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care Platform
    From PAVmed Inc.
    Via Business Wire
    News headline image
    Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer Research
    From Lucid Diagnostics Inc.
    Via Business Wire
    News headline image
    PAVmed Provides Business Update and Third Quarter 2022 Financial Results
    From PAVmed Inc.
    Via Business Wire
    News headline image
    Lucid Diagnostics Provides Business Update and Third Quarter 2022 Financial Results
    From Lucid Diagnostics Inc.
    Via Business Wire
    News headline image
    Lucid Diagnostics to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum
    From Lucid Diagnostics Inc.
    Via Business Wire
    News headline image
    Lucid Diagnostics Commences Production of EsoCheck Devices with High-Volume Manufacturer
    From Lucid Diagnostics Inc.
    Via Business Wire
    News headline image
    Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 14, 2022
    From Lucid Diagnostics Inc.
    Via Business Wire
    News headline image
    Lucid Diagnostics Provides Business Update and Preliminary Second Quarter 2022 Financial Results
    From Lucid Diagnostics Inc.
    Via Business Wire
    News headline image
    Lucid Diagnostics Launches Stage II Lucid Test Center Expansion in California, Texas, Florida, and Ohio
    From Lucid Diagnostics Inc.
    Via Business Wire
    News headline image
    Newly Published American Gastroenterological Association Clinical Practice Update Supports Esophageal Precancer Screening Using Lucid Diagnostics’ EsoGuard® and EsoCheck® Technologies
    From Lucid Diagnostics Inc.
    Via Business Wire
    News headline image
    Lucid Diagnostics’ Laboratory Executes Four New Participating Provider Agreements
    From Lucid Diagnostics Inc.
    Via Business Wire
    News headline image
    Lucid Diagnostics to Hold a Business Update Conference Call on August 15, 2022
    From Lucid Diagnostics Inc.
    Via Business Wire
    News headline image
    Lucid Diagnostics to Participate in the Canaccord 42nd Annual Growth Conference and the 7th Annual Needham Med Tech & Diagnostics 1x1 Conference
    From Lucid Diagnostics Inc.
    Via Business Wire
    News headline image
    Lucid Diagnostics Provides Business Update and Preliminary First Quarter 2022 Financial Results
    From Lucid Diagnostics Inc.
    Via Business Wire
    News headline image
    PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEO
    From PAVmed Inc.
    Via Business Wire
    News headline image
    Lucid Diagnostics to Hold a Business Update Conference Call on May 11, 2022
    From Lucid Diagnostics Inc.
    Via Business Wire
    News headline image
    Lucid Diagnostics’ Laboratory Executes Participating Provider Agreement with MediNcrease Health Plans
    From Lucid Diagnostics Inc.
    Via Business Wire
    News headline image
    PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results
    From PAVmed Inc.
    Via Business Wire
    News headline image
    Lucid Diagnostics Provides Updates on Newly Published Esophageal Precancer Clinical Guideline and Proposed Medicare Local Coverage Determination
    From Lucid Diagnostics Inc.
    Via Business Wire
    News headline image
    Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results
    From Lucid Diagnostics Inc.
    Via Business Wire
    News headline image
    Lucid Diagnostics to Participate in the Needham 21st Annual Healthcare Conference
    From Lucid Diagnostics Inc.
    Via Business Wire
    News headline image
    PAVmed Subsidiary Lucid Diagnostics Announces Launch of VA EsoGuard® Study
    From Lucid Diagnostics Inc.
    Via Business Wire
    News headline image
    PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers
    From Lucid Diagnostics Inc.
    Via Business Wire
    News headline image
    PAVmed Appoints Shaun O’Neil as Chief Operating Officer
    From PAVmed Inc.
    Via Business Wire
    News headline image
    Evernorth Executive and Healthcare Services Industry Leader Joan Harvey Named to PAVmed Board of Directors
    From PAVmed Inc.
    Via Business Wire
    < Previous 1 2 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.